07:00 , Aug 22, 2011 |  BC Week In Review  |  Clinical News

Propel mometasone furoate implant regulatory update

FDA approved a PMA from Intersect for Propel mometasone furoate implant to treat chronic sinusitis. Intersect plans to launch the bioabsorbable, steroid-eluting implant this fall. Intersect ENT Inc., Palo Alto, Calif.   Product: Propel mometasone...